Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trang Ly

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Lancet. Diabetes & Endocrinology|February 7, 2016
Closed-loop control in type 1 diabetesBruce Buckingham, Trang Ly
Diabetes, Obesity & Metabolism|September 7, 2020
Patient-reported outcomes in a study of human regular U-500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetesJieling Chen, Ludi Fan, Xiaomei Peng, et al.
Diabetes Care|February 24, 2019
Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionDessi P Zaharieva, Sarah McGaugh, Rubin Pooni, et al.
Journal of Diabetes Science and Technology|February 25, 2016
Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient BehaviorMartin de Bock, Matthew Cooper, Adam Retterath, et al.
Diabetes Technology & Therapeutics|May 7, 2019
Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 DiabetesDessi P Zaharieva, Kamuran Turksoy, Sarah M McGaugh, et al.
Journal of Diabetes Science and Technology|July 2, 2021
Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 DiabetesXiaosu Ma, Timothy Waterhouse, Liza L Ilag, et al.
Diabetes Technology & Therapeutics|July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID StudyThomas Blevins, Wendy Lane, David Rodbard, et al.
Diabetes, Obesity & Metabolism|December 23, 2019
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID studyGeorge Grunberger, Anuj Bhargava, Trang Ly, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 30, 2021
The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc AnalysisRobert C Hood, Yun Chen, Dana K Sindelar, et al.
Diabetes Care|August 14, 2015
Effect of acetaminophen on CGM glucose in an outpatient settingDavid M Maahs, Daniel DeSalvo, Laura Pyle, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Lancet. Diabetes & Endocrinology|February 7, 2016
Closed-loop control in type 1 diabetesBruce Buckingham, Trang Ly
Diabetes, Obesity & Metabolism|September 7, 2020
Patient-reported outcomes in a study of human regular U-500 insulin delivered by continuous subcutaneous insulin infusion or multiple daily injections in patients with type 2 diabetesJieling Chen, Ludi Fan, Xiaomei Peng, et al.
Diabetes Care|February 24, 2019
Improved Open-Loop Glucose Control With Basal Insulin Reduction 90 Minutes Before Aerobic Exercise in Patients With Type 1 Diabetes on Continuous Subcutaneous Insulin InfusionDessi P Zaharieva, Sarah McGaugh, Rubin Pooni, et al.
Journal of Diabetes Science and Technology|February 25, 2016
Continuous Glucose Monitoring Adherence: Lessons From a Clinical Trial to Predict Outpatient BehaviorMartin de Bock, Matthew Cooper, Adam Retterath, et al.
Diabetes Technology & Therapeutics|May 7, 2019
Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 DiabetesDessi P Zaharieva, Kamuran Turksoy, Sarah M McGaugh, et al.
Journal of Diabetes Science and Technology|July 2, 2021
Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 DiabetesXiaosu Ma, Timothy Waterhouse, Liza L Ilag, et al.
Diabetes Technology & Therapeutics|July 8, 2020
Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID StudyThomas Blevins, Wendy Lane, David Rodbard, et al.
Diabetes, Obesity & Metabolism|December 23, 2019
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID studyGeorge Grunberger, Anuj Bhargava, Trang Ly, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 30, 2021
The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc AnalysisRobert C Hood, Yun Chen, Dana K Sindelar, et al.
Diabetes Care|August 14, 2015
Effect of acetaminophen on CGM glucose in an outpatient settingDavid M Maahs, Daniel DeSalvo, Laura Pyle, et al.
Pageof 2